Search

PHTRP lists its fifth AMR and phage therapy panel discussion, “Building a Career in Phage Research.” Phage Hunters Training and Research Program

An International Journal of Infectious Diseases case report from the Military University Hospital Prague describes a 60-year-old woman with chronic MRSA vertebral osteomyelitis and non-removable spinal instrumentation who received 35 intrav

UMC Utrecht has received a 4 million euro grant from the Promising Care scheme of the National Healthcare Institute and ZonMw for the first clinical study in the Netherlands of customized bacteriophage therapy for recurrent urinary tract in

BiomX announced on December 8, 2025 that it was discontinuing its Phase 2b trial of BX004 in cystic fibrosis patients with chronic Pseudomonas aeruginosa infections, saying the time and resources needed for the alternative dosing strategy r

Barril, Bardina and Cuadrado (Universitat Autònoma de Barcelona) propose a mathematical model of phage therapy with encapsulated bacteriophages in the gastrointestinal tract. Microcapsules protect phages from degradation in acidic environme

Biofilm-adapted mutants of Pseudomonas phage PE1, evolved on a cystic fibrosis-derived P. aeruginosa isolate, controlled biofilms better in vitro under conditions mimicking the CF lung. Mutations in tail fiber and baseplate genes improved a

The Centre of Biological Engineering at the University of Minho is leading the establishment of a Laboratory for the Production of Therapeutic Phages to address antibiotic resistance. University of Minho / CEB

Australia's Therapeutic Goods Administration consulted on a proposed time-limited GMP exemption for manufacturers of personalised bacteriophage therapy products, which are currently supplied as unapproved goods under the Special Access Sche

Baylor University will partner with academic and industry investigators on MIGHTY, a five-year initiative funded up to $28 million by ARPA-H. The project aims to develop a precision phage platform, starting with oral health. Aaron Wright wi

We are urgently seeking Pseudomonas aeruginosa phages for a patient in the USA. This is a pan-resistant strain. Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain

Project coordinator Esme discussed using phage therapy to treat urinary tract infections with Melissa Kramer of Live UTI Free. The Phage Collection Project

Science journalist Thomas Häusler has created a 25-minute documentary about phage therapy. Commissioned by the Swiss Academy of Natural Sciences, it has been just released on their YouTube channel. The film tells the story of a patient wit

Entelli-02 is a five-phage cocktail built from The Alfred Hospital's decade-long isolate collection against multidrug-resistant Enterobacter cloacae complex; it covers 88% of the hospital's 206 isolates and reduced bacterial load in septica

MicrobiotiX, a Korean bacteriophage-therapy company, completed an extended Series B totaling 20 billion KRW (29 billion KRW raised across rounds). It was also selected for the Korean Ministry of Health and Welfare's Infectious Disease Preve

Why don't we have phage therapy yet? We want to understand why. On the Podovirus podcast, we interview people we think could have the answers. 🎙️ Most recent episode: Joe and Jessica interviewed Dr. Saima Aslam, clinical lead at IPATH abo

Jessica was interviewed on the Development & Research podcast, a new video interview series by biotech investor/economist Ross Rheingans-Yoo about people doing things differently in clinical trials and drug development. They discussed oper

Feature on the Reference Center for Complex Osteoarticular Infections (CrioaC) at Croix-Rousse Hospital in Lyon, where Professor Tristan Ferry's team treats patients at a therapeutic impasse with phages, a treatment the service has pioneere

In a Form 8-K dated August 19, 2025, BiomX reported that the FDA placed a clinical hold on its Phase 2b study of BX004 in cystic fibrosis while it reviews data on a third-party nebulizer used to deliver BX004. The FDA raised no concerns abo

Saima Aslam and colleagues at University of California, San Diego have announced Phase I/II phage vs placebo trial for recurrent E. coli UTIs in female kidney transplant recipients.

We are urgently seeking Burkholderia multivorans phages for a cystic fibrosis patient in France Ways to help at this stage: - By sending your phages for testing on the patient's strains - By receiving the patient's strain and testing your